In a previous paper,1 the present authors reported a family of vitamin B6 dependent xanthurenic aciduria. The patients showed an excessive output of xanthurenic acid, kynurenic acid, 3-hydroxykynurenine and kynurenine in urine following an oral tryptophan loading. The metabolic disturbance was normalized temporarily by the administration of large doses of vitamin B6. Enzyme studies on the liver specimen obtained from the patient showed that the activity of kynurenin ase was markedly reduced without an addition of pyridoxal phosphate (PALP), but it was restored nearly to the normal level by the addition of an excess of PALP.
Recently we had an opportunity of investigating another family of the same disorder and could confirm the biochemical findings of the previous patients.
In this paper, the clinical and biochemical findings in the patients of the second family, together with additional findings in the patients of the first family will be described.
REPORT OF CASES
Case S.S., a two-year-old girl was referred to our Clinic with a chief complaint of mental retardation.
She was born after an uncomplicated full term pregnancy and spontaneous delivery.
Her neonatal history was uneventful. She was fed on cow's milk formula and did not take any vitamin preparations in infancy. She has often suffered from stomatitis.
There was no history of convulsions. The parents were healthy and not consanguineous. There was a sibling (Case J.S.).
Physical examination on admission revealed a moderately nourished girl with a dull countenance. Weight and height were within normal limits. DQ was found to be below 50. Otherwise, there were no abnormal findings on physical examina tions.
Routine laboratory findings, including hematological examination, urinalysis, the values of electrolytes, lipids, protein and sugar in blood and liver function tests , were all within normal range.
Electroencephalogram in sleeping records indicated dysrhythmia with sporadic sharp waves and HVS in all areas. Pneumoencephalography showed cerebrocortical atrophy and dilatation of the ventricles.
Case J.S., a sister of S.S., was examined at the age of 3 years. She was born normally and fed on cow's milk formula in infancy. Throughout the infancy , she had took a vitamin preparation containing 2mg of vitamin B6 and 20mg of nicotinic acid in daily dosis. There was no history of convulsions.
On admission, she was within the normal range in physical size. DQ was found to be 98. But, mild retardation of speech development was found without any abnormality on otorhinolaryngological examinations . Otherwise, there were no remarkable findings on physical examinations . Routine laboratory examinations showed almost normal findings.
Electroencephalogram in sleeping records exhibited sporadic sharp waves and HVS in all areas.
Two-dimensional thin-layer chromatography of urinary amino acids in both the patients showed an almost normal pattern. The serum amino acid levels by an automatic amino acid analyzer were within normal limits (cf . Table 1 ). Tryptophan loading test: L-Tryptophan (100mg/kg) was orally given and 24 -hour urine specimens were collected following the test dose. The urine specimens were investigated for tryptophan metabolites by two-dimensional thin-layer chromatography as described in our previous paper.1 The patient's urine contained excessive amounts of xanthurenic acid (XA), kynurenic acid (KA), 3-hydroxykynurenine (HK) and kynurenine (K) (cf. Table 2 ). This pattern of urinary tryptophan metabolites agrees with that found in our previous patients of B6 dependent xanthurenic aciduria.
The activities of erythrocyte GOT (glutamic oxaloacetic transaminase), which were thought to be parallel with the amounts of PALP in blood,14 were within normal limits in these patients (cf. Table 3 ).
The amounts of urinary pyridoxic acid, which is a final metabolite of vitamin B6, were estimated by Reddy et al.'s method. 2 The patients showed normal amounts of pyridoxic acid in urine (cf. Table 4) . From these results, the possibility3 of a disturbance in the intestinal absorption of B6 or an increased oxidation of vitamin B6 to pyridoxic acid can be excluded. Response to vitamin B6 administration: Various doses of pyridoxine or pyri doxal phosphate were given parenterally to the patients and urinary output of XA following the tryptophan loading was determined. In each schedule, the same amount of B6 was administered for three consecutive days and the tryptophan loading test was performed on the third day. The results showed that large doses of pyridoxine or pyridoxal phosphate were temporarily effective in reducing XA excretion of these particular patients to the normal levels (cf. Fig. 1 ). It was also found that pyridoxal phosphate was effective in less amounts than pyridoxine. But the XA excretion returned to the increased levels three to seven days after the cessation of B6 treatment. Fig. 2 shows the quantitative values of XA, KA, K and pyridone in urine following the tryptophan loading during the treatment with pyridoxine in Case S.S. During the administration of pyridoxine in excess, urinary output of XA, KA and K was found to diminish and on the contrary pyridone excretion was found to increase. These results clearly indicate that the Fig. 1 disturbance in the process catalyzed by kynureninase in the patient is temporarily normalized by large doses of pyridoxine (cf. Fig. 3 ).
Family studies: The parents of the patients were subjected to the tryptophan loading test. The father showed xanthurenic aciduria, but the mother was found to be normal (cf. Table 2 ).
ENZYME STUDIES
The liver specimens were surgically obtained from the patient (Case S.S.). As controls, the liver specimens were obtained at laparotomy of several surgical patients without liver involvement. The biopsied liver specimens were immediate ly homogenized with 2 volumes of 0.14 M KCl and centrifuged at 4,000rpm for 20 minutes at 0°C. Using the supernatant (soluble liver extract) thus obtained, the activity of kynureninase was determined by Knox's method. 4 The results were shown in Fig. 4 , together with the data of the patient of the first family described previously.1 Without an addition of PALP, the control livers showed high activity of kynureninase because of sufficient amount of PALP of endogenous origin . On the other hand, the patient's liver showed a markedly low activity without addi tion of PALP. The kynureninase activity in the patient's liver however, was restored to the almost normal level with addition of an excess of PALP . In other words, the effect of PALP added in excess was more remarkable in the patient's liver than in control livers. These results could be considered possibly to be due to the deficiency in PALP content of the patient's liver. But the deficiency in PALP can be denied from the in vivo observation of these patients. It is, therefore, reasonable to conclude that there is a disturbance in binding between kynureninase (apoenzyme) and PALP (coenzyme) in this particular disorder.
COMMENT
In the previous paper,1 the authors have stated that the primary lesion of B6 dependent xanthurenic aciduria lies in an altered association of apoenzyme (kynureninase) with coenzyme (PALP) probably due to the genetic mutation of the binding site of apoenzyme with coenzyme. This view was re-affirmed by the present studies of the patients of the second family with the same disorder.
The enzyme studies of the liver revealed that a higher dosis of PALP was necessary to restore the activity of kynureninase in the liver of Case S.S. (the second family) than in the liver of Case H.S. (the first family). In parallel with the results of in vitro studies of the liver, larger amounts of B6 were in vivo necessary to reduce XA excretion in Case S.S. than in Case H.S.
In clinical aspects of the disorder, Case S.S. showed severe mental retarda tion, but her sister, Case J.S. did not show mental retardation except for a delay in speech development. In this respect. it is of interest that Case J.S. had been given a vitamin preparation containing B6 and nicotinic acid throughout infancy, while Case S.S. had not been given one. There is the possibility that the disturbance in the conversion of tryptophan to nicotinic acid results in deficiency of endogenous nicotinic acid and affects mental development, which progresses rapidly in infancy. Nicotinic acid is known to be incorporated into the functional group of two phospho pyridine nucleotide coenzymes, DPN and TPN, which are essential for energy -producing reactions of cellular physiology. ' It is, therefore, probable that the tissues with high energy requirements such as the developing brain are apt to be particularly affected. If it is the case, the development of mental defect in this particular disorder may be influenced by the intake of nicotinic acid and vitamin B6. Similar examples are seen in homocystinuria. In cousin cases of homocystinuria described by Wright, 5 the seriously affected patient with mental retardation had received only cow's milk during infancy, while the cousin without mental retarda tion had received human milk. It is known that cow's milk is a relatively poor source of cystine, while human milk is a richer source of cystine. In homo cystinuria, cystine becomes an essential amino acid because of a defect in cystathionine synthetase.
Therefore, Wright assumed that the difference in nutritional condition in infancy may be related to the degree of mental defect.
In 1964, Komrower et al.6 reported 'hydroxykynureninuria', which was charac terized by an excessive excretion of HK, XA, KA and K in urine. In their patient, large dosis of B6 (50mg/day) exerted no effect in changing the metabolic abnormality and they postulated that the disorder might be due to deficiency in kynureninase.
In 1963, the present authors8 reported `congenital tryptophanuria' probably due to deficiency in tryptophan pyrrolase. These two disorders are common in the block of the conversion of tryptophan to nicotinic acid on metabolic basis and in mental retardation accompanied by pellagra-like syndrome. These findings seem to favor the concept that the endogenous deficiency in nicotinic acid may be responsible for mental retardation.
Among the patients with B6 dependent xanthurenic aciduria so far reported, most of them1,9,10 are mentally defective except for Knapp's cases,11 in which the metabolic lesion is probably milder.
The degree of mental retardation may depend on the severity of metabolic lesion on the one hand and may be influenced by nutritional factors (intake of nicotinic acid and vitamin B6) on the other.
